REEDOS 5 lamotrigine 5 mg dispersible/chewable tablets bottle

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

lamotrigine, Quantity: 5 mg

Dostępny od:

Strides Pharma Science Pty Ltd

INN (International Nazwa):

Lamotrigine

Forma farmaceutyczna:

Tablet, dispersible

Skład:

Excipient Ingredients: povidone; magnesium stearate; sucralose; polacrilin potassium; microcrystalline cellulose; magnesium carbonate hydrate; Flavour

Droga podania:

Oral

Sztuk w opakowaniu:

56, 30

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,There is extensive experience with Lamotrigine used initially as ?add-on? therapy. The use of Lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

Podsumowanie produktu:

Visual Identification: White to off-white capsule shaped uncoated tablets debossed with 'H' on one side and '81' on other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Registered

Data autoryzacji:

2012-05-03